IDO1 and cancer: In this context, non-steroidal anti-inflammatory drugs, which are COX-2 inhibitors, could at the same time lower PGE2 levels and IDO1 expression, leading to Treg cell downmodulation as seen in the reversion of tumor immune evasion in cancer models53,90.